Ajanta Pharma informs about outcome of board meeting

31 Oct 2018 Evaluate

Pursuant to Regulations 33, 42 & 43 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that Board of Directors of Company at their meeting held on 31st October, 2018, has approved Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2018; Unaudited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2018; and Payment of interim dividend of Rs 9 (450%) per equity share on the face-value of Rs 2 per share for the Financial Year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2716.05 16.35 (0.61%)
27-Jan-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.70
Dr. Reddys Lab 1246.00
Cipla 1297.20
Zydus Lifesciences 891.85
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×